An overview of emergency pharmacotherapy for priapism

References

• Bivalacqua TJ, Allen BK, Brock G, et al., Acute ischemic priapism: an AUA/SMSNA guideline. J Urol. 206(5): 1114–1121. 2021.
   PubMed Web of Science ®Google Scholar
• Earle CM, Stuckey BG, Ching HL, et al. The incidence and management of priapism in Western Australia: a 16 year audit. Int J Impot Res. 2003;15(4):272–276.
   PubMed Web of Science ®Google Scholar
• Roghmann F, Becker A, Sammon JD, et al. Incidence of priapism in emergency departments in the United States. J Urol. 2013;190(4):1275–1280.
   PubMed Web of Science ®Google Scholar
• Podolej GS, Babcock C. Emergency department management of priapism. Emerg Med Pract. 2017;19(1):1–16.
   PubMedGoogle Scholar
• Eland IA, van der Lei J, Stricker BH, et al. Incidence of priapism in the general population. Urology. 2001;57(5):970–972.
   PubMed Web of Science ®Google Scholar
• Tranekær S, Hansen DL, Biemond BJ, et al. Priapism in patients with hemolytic disorders: a nationwide retrospective cohort study. Ann Hematol. 2021;100(8):1947–1951.
   PubMed Web of Science ®Google Scholar
• Pohl J, Pott B, Kleinhans G. Priapism: a three-phase concept of management according to aetiology and prognosis. Br J Urol. 1986;58(2):113–118.
   PubMedGoogle Scholar
• Hinman F. Priapism: report of cases and a clinical study of the literature with reference to its pathogenesis and surgical treatment. Ann Surg. 1914;60(6):689–716.
   PubMedGoogle Scholar
• Spycher MA, Hauri D. The ultrastructure of the erectile tissue in priapism. J Urol. 1986;135(1):142–147.
   PubMed Web of Science ®Google Scholar
• Anele UA, Burnett AL. Erectile dysfunction after sickle cell disease-associated recurrent ischemic priapism: profile and risk factors. J Sex Med. 2015;12(3):713–719.
   PubMed Web of Science ®Google Scholar
• El-Bahnasawy MS, Dawood A, Farouk A. Low-flow priapism: risk factors for erectile dysfunction. BJU Int. 2002;89(3):285–290.
   PubMed Web of Science ®Google Scholar
• Morrison BF, Madden W, Asnani M, et al. External validation of the priapism impact profile in a Jamaican cohort of patients with sickle cell disease. PloS One. 2021;16(10):e0258560.
   PubMed Web of Science ®Google Scholar
• Salonia A, Eardley I, Giuliano F, et al., European Association of Urology guidelines on priapism. Eur Urol. 65(2): 480–489. 2014.
   PubMed Web of Science ®Google Scholar
• National Center for Biotechnology Information. PubChem compound summary for CID 5284443, Phenylephrine hydrochloride. [cited 2022 Mar 20]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Phenylephrine-hydrochloride
   Google Scholar
• McEvoy GK American hospital formulary service. AHFS drug information. Bethesda (MD): American Society of Health-System Pharmacists; 2007. p. 1296.
   Google Scholar
• National Center for Biotechnology Information. PubChem compound summary for CID 9581, Pseudoephedrine hydrochloride. [cited 2022 Mar 20]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Pseudoephedrine-hydrochloride
   Google Scholar
• Pawlaczyk M, Korzeniowska K, Jabłecka A. Safety and efficacy of pseudoephedrine. Farm. WSP. 2017;10:67–71.
   Google Scholar
• Spitzbarth H. Erfahrungen mit Effortil bei arterieller Hypotonie [Results with effortil in arterial hypotension]. Med Klin. 1950;45(50):1593–1596.
   PubMedGoogle Scholar
• Hengstmann JH, Weyand U, Dengler HJ. The physiological disposition of etilefrine in man. Eur J Clin Pharmacol. 1975;9(2–3):179–187.
   PubMed Web of Science ®Google Scholar
• National Center for Biotechnology Information. PubChem compound summary for CID 5906, Metaraminol. [cited 2022 Mar 20]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Metaraminol
   Google Scholar
• Hathaway DE. Kinetics of Drug absorption, distribution, biotransformation, and excretion. In: Foreign compound metabolism in mammals. 1st ed. vol.1. pp. 98–129. UK: Royal Society of Chemistry; 1970
   Google Scholar
• National Center for Biotechnology Information. PubChem compound summary for CID 3821, Ketamine. [cited 2022 Mar 20]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Ketamine
   Google Scholar
• Clements JA, Nimmo WS, Grant IS. Bioavailability, pharmacokinetics, and analgesic activity of ketamine in humans. J Pharm Sci. 1982;71(5):539–542.
   PubMed Web of Science ®Google Scholar
• Karch SB, and Drummer OH. Dissociative anesthetics. In: Karch’s pathology of drug abuse. 5th ed. Boca Raton, FL: CRC Press; 2015. p. 697–754.
   Google Scholar
• Fanta S, Kinnunen M, Backman JT, et al. Population pharmacokinetics of S-ketamine and norketamine in healthy volunteers after intravenous and oral dosing. Eur J Clin Pharmacol. 2015;71(4):441–447.
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration. (n.d.). [cited 2022 Mar 20]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/204630s000lbl.pdf
   Google Scholar
• Food and Drug Administration. (n.d.). [cited 2022 Mar 20]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/204200s000lbl.pdf
   Google Scholar
• Daily Med U.S National Library of Medicine. [cited 2022 Mar 20]. Available from: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fbf54709-5857-4dbc-9233-ebd7abff88c8
   Google Scholar
• Food and Drug Administration. (n.d.). [cited 2022 Mar 20]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/018533s040lbl.pdf
   Google Scholar
• Martin C, Cocchio C. Effect of phenylephrine and terbutaline on ischemic priapism: a retrospective review. Am J Emerg Med. 2016;34(2):222–224.
   PubMed Web of Science ®Google Scholar
• Yafi FA, April D, Powers MK, et al. Penile priapism, clitoral priapism, and persistent genital arousal disorder: a contemporary review. Sex Med Rev. 2015;3(3):145–159.
   PubMedGoogle Scholar
• Wen CC, Munarriz R, McAuley I, et al. Management of ischemic priapism with high-dose intracavernosal phenylephrine: from bench to bedside [published correction appears in J Sex Med. 2006 Sep;3(5):938]. J Sex Med. 2006;3(5):918–922.
   PubMed Web of Science ®Google Scholar
• Glowacka K, Wiela-Hojeńska A. Pseudoephedrine-benefits and risks. Int J Mol Sci. 2021;22(10):5146.
   PubMed Web of Science ®Google Scholar
• Lowe FC, Jarow JP. Placebo-controlled study of oral terbutaline and pseudoephedrine in management of prostaglandin E1-induced prolonged erections. Urology. 1993;42(1):51–54.
   PubMed Web of Science ®Google Scholar
• Virag R, Bachir D, Lee K, et al. Preventive treatment of priapism in sickle cell disease with oral and self-administered intracavernous injection of etilefrine. Urology. 1996;47(5):777–781.
   PubMed Web of Science ®Google Scholar
• Gbadoé AD, Atakouma Y, Kusiaku K, et al. Management of sickle cell priapism with etilefrine. Arch Dis Child. 2001;85(1):52–53.
   PubMed Web of Science ®Google Scholar
• Chinegwundoh FI, Smith S, Anie KA. Treatments for priapism in boys and men with sickle cell disease. Cochrane Database Syst Rev. 2020;4(4):CD004198.
   PubMedGoogle Scholar
• McDonald M, Santucci RA. Successful management of stuttering priapism using home self-injections of the alpha-agonist metaraminol. Int Braz J Urol. 2004;30(2):121–122.
   PubMedGoogle Scholar
• Johnson JW, Glasgow NG, Povysheva NV. Recent insights into the mode of action of memantine and ketamine. Curr Opin Pharmacol. 2015;20:54–63.
   PubMed Web of Science ®Google Scholar
• Mathew S. Ketamine for treatment-resistant unipolar depression: current evidence. CNS Drugs. 2012;26(3):189–204.
   PubMed Web of Science ®Google Scholar
• Gale AS. Ketamine prevention of penile turgescence. JAMA. 1972;219(12):1629.
   PubMed Web of Science ®Google Scholar
• Steers WD, Selby JB Jr. Use of methylene blue and selective embolization of the pudendal artery for high flow priapism refractory to medical and surgical treatments. J Urol. 1991;146(5):1361–1363.
   PubMed Web of Science ®Google Scholar
• Gachot B, Bedos JP, Veber B, et al. Short-term effects of methylene blue on hemodynamics and gas exchange in humans with septic shock. Intensive Care Med. 1995;21(12):1027–1031.
   PubMed Web of Science ®Google Scholar
• Hübler J, Szántó A, Könyves K. Methylene blue as a means of treatment for priapism caused by intracavernous injection to combat erectile dysfunction. Int Urol Nephrol. 2003;35(4):519–521.
   PubMedGoogle Scholar
• Martínez Portillo FJ, Fernández Arancibia MI, Bach S, et al. Azul de metileno: una efectiva alternativa terapéutica para el priapismo inducido por inyección intracavernosa de sustancias vasoactivas [Methylene blue: an effective therapeutic alternative for priapism induced by intracavernous injection of vasoactive agents]. Arch Esp Urol. 2002;55(3):303–308.
   PubMedGoogle Scholar
• Shantha TR. Intraoperative management of penile erection by using terbutaline. Anesthesiology. 1989;70(4):707–709.
   PubMed Web of Science ®Google Scholar
• Shantha TR, Finnerty DP, Rodriquez AP. Treatment of persistent penile erection and priapism using terbutaline. J Urol. 1989;141(6):1427–1429.
   PubMed Web of Science ®Google Scholar
• Priyadarshi S. Oral terbutaline in the management of pharmacologically induced prolonged erection. Int J Impot Res. 2004;16(5):424–426.
   PubMed Web of Science ®Google Scholar
• Ridyard DG, Phillips EA, Vincent W, et al. Use of high-dose phenylephrine in the treatment of ischemic priapism: five-year experience at a single institution. J Sex Med. 2016;13(11):1704–1707.
   PubMed Web of Science ®Google Scholar
• Okpala I, Westerdale N, Jegede T, et al. Etilefrine for the prevention of priapism in adult sickle cell disease. Br J Haematol. 2002;118(3):918–921.
   PubMed Web of Science ®Google Scholar
• Song Y, Song YS. Diagnosis and treatment of priapism: a report of 15 cases. Zhonghua Nan Ke Xue. 2008;14(9):829–831.
   PubMedGoogle Scholar
• Tang M, Liu B, Li J, et al. Intracavernosal metaraminol bitartrate for treatment of priapism resulting from circumcision: a case report. Springerplus. 2016;5(1):436.
   PubMedGoogle Scholar
• Block T, Sturm W, Ernst G, et al. Metaraminol in der Therapie verschiedener Priapismusformen [Metaraminol in therapy of various forms of priapism]. Urologe A. 1988;27(4):225–229.
   PubMedGoogle Scholar
• Park DB, Hayden GE. Ketamine saves the day. Pediatr Emerg Care. 2015;31(7):508–510.
   PubMed Web of Science ®Google Scholar
• Stothers L, Ritchie B. Priapism in the newborn. Can J Surg. 1992;35(3):325–326.
   PubMed Web of Science ®Google Scholar
• Das J, Deuri A, Roy PM, et al. Priapism during transurethral surgery under spinal anaesthesia: implications and review of management options. Indian J Anaesthesia. 2010;54(6):576–577.
   PubMedGoogle Scholar
• Mantadakis E, Ewalt DH, Cavender JD, et al. Outpatient penile aspiration and epinephrine irrigation for young patients with sickle cell anemia and prolonged priapism. Blood. 2000;95(1):78–82.
   PubMed Web of Science ®Google Scholar
• Roberts JR, Price C, Mazzeo T. Intracavernous epinephrine: a minimally invasive treatment for priapism in the emergency department. J Emerg Med. 2009;36(3):285–289.
   PubMed Web of Science ®Google Scholar
• Evans KC, Peterson AC, Ruiz HE, et al. Use of oral ketoconazole to prevent postoperative erections following penile surgery. Int J Impot Res. 2004;16(4):346–349.
   PubMed Web of Science ®Google Scholar
• DeCastro BJ, Costabile RA, McMann LP, et al. Oral ketoconazole for prevention of postoperative penile erection: a placebo controlled, randomized, double-blind trial. J Urol. 2008;179(5):1930–1932.
   PubMed Web of Science ®Google Scholar
• Sidhu AS, Wayne GF, Kim BJ, et al. The hemodynamic effects of intracavernosal phenylephrine for the treatment of ischemic priapism. J Sex Med. 2018;15(7):990.
   PubMed Web of Science ®Google Scholar
• Palagiri RDR, Chatterjee K, Jillella A, et al. A case report of hypertensive emergency and intracranial hemorrhage due to intracavernosal phenylephrine. Hosp Pharm. 2019;54(3):186.
   PubMed Web of Science ®Google Scholar
• Davila HH, Parker J, Webster JC, et al. Subarachnoid hemorrhage as complication of phenylephrine injection for the treatment of ischemic priapism in a sickle cell disease patient. J Sex Med. 2008;5(4):1025.
   PubMed Web of Science ®Google Scholar
• Olujohungbe AB, Adeyoju A, Yardumian A, et al. A prospective diary study of stuttering priapism in adolescents and young men with sickle cell anemia: report of an international randomized control trial--the priapism in sickle cell study. J Androl. 2011;32(4):375–382.
   PubMedGoogle Scholar
• Bettocchi C, Sebastiani F, Spilotros M, et al. Efficacy and safety of etilefrine as priapism prophylaxis in patients submitted to penile dynamic colour doppler ultrasonography: a retrospective study on 750 prospectively collected patients. JSM Sexual Med. 2020;4(6):1048.
   Google Scholar
• Eroğlu A, Tuncalı B, Ekin R. The utility of intravenous ketamine for the management of intraoperative penile erection: a retrospective single-center analysis of endourological surgeries over a 4-year. BMC Urol. 2020;20(1):4.
   PubMed Web of Science ®Google Scholar
• Roberts J, Isenberg DL. Adrenergic crisis after penile epinephrine injection for priapism. J Emerg Med. 2009;36(3):309–310.
   PubMed Web of Science ®Google Scholar
• Hoeh MP, Levine LA. Prevention of recurrent ischemic priapism with ketoconazole: evolution of a treatment protocol and patient outcomes. J Sex Med. 2014;1(1):197–204.
   Google Scholar
• Cintho Ozahata M, Page GP, Guo Y, et al. Clinical and genetic predictors of priapism in sickle cell disease: results from the recipient epidemiology and donor evaluation study III Brazil cohort study. J Sex Med. 2019;16(12):1988–1999.
   PubMed Web of Science ®Google Scholar
• Muruve N, Hosking DH. Intracorporeal phenylephrine in the treatment of priapism. J Urol. 1996;155(1):141.
   PubMed Web of Science ®Google Scholar